End-stage Renal Disease
📧 Sign up to get email alerts when something new happens for End-stage Renal Disease.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2013-04-26FDA Approved: DIANEAL PD-2 WITH DEXTROSE — Supplemental Application (Vantive US Healthcare LLC)
The FDA approved a supplemental application for Dianeal PD-2 with Dextrose, a peritoneal dialysis solution, with manufacturing by Vantive US…
-
FDA approval · 2013-04-19FDA Approved: DIANEAL PD-2 WITH DEXTROSE — Supplemental Application (Vantive US Healthcare LLC)
The FDA approved a supplemental application for Dianeal PD-2 with Dextrose, a peritoneal dialysis solution, submitted by Vantive US Healthca…
-
FDA approval · 2013-04-19FDA Approved: DIANEAL LOW CALCIUM WITH DEXTROSE — Supplemental Application (Vantive US Healthcare LLC)
FDA approved a supplemental application for Dianeal Low Calcium with Dextrose (a peritoneal dialysis solution) submitted by Vantive US Healt…
-
FDA approval · 2013-04-19FDA Approved: DIANEAL LOW CALCIUM WITH DEXTROSE — Supplemental Application (Vantive US Healthcare LLC)
The FDA approved a supplemental application for Dianeal Low Calcium with Dextrose, a peritoneal dialysis solution, manufactured by Vantive U…
-
FDA approval · 2013-04-18FDA Approved: DELFLEX — Supplemental Application (Fresenius Medical Care de Mexico, S.A. de C.V.)
FDA approved a supplemental application for DELFLEX, a dialysis solution containing dextrose and electrolytes, manufactured by Fresenius Med…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2013-04-18FDA Approved: DELFLEX — Supplemental Application (Fresenius Medical Care North America)
The FDA approved a supplemental application for DELFLEX, a dialysis solution, submitted by Fresenius Medical Care North America.
-
FDA approval · 2013-02-22FDA Approved: DELFLEX — Supplemental Application (Fresenius Medical Care North America)
FDA approved a supplemental application for DELFLEX submitted by Fresenius Medical Care North America, updating its formulation to include d…
-
FDA approval · 2013-02-05FDA Approved: CALCIUM ACETATE — Original Application (Chartwell RX LLC)
FDA approves Chartwell RX LLC's calcium acetate as a new generic phosphate binder under an Original Application (ANDA 202420).
-
FDA approval · 2013-01-30FDA Approved: DELFLEX — Supplemental Application (Fresenius Medical Care de Mexico, S.A. de C.V.)
FDA approved a supplemental application for DELFLEX, a dialysis solution from Fresenius Medical Care de Mexico, S.A. de C.V.
-
FDA approval · 2013-01-30FDA Approved: DELFLEX — Supplemental Application (Fresenius Medical Care North America)
FDA approved a supplemental application for DELFLEX, a dialysis solution, from Fresenius Medical Care North America.
-
FDA approval · 2011-09-02FDA Approved: FOSRENOL — Supplemental Application (Takeda Pharmaceuticals America, Inc.)
FDA approved a supplemental application for Fosrenol (lanthanum carbonate) submitted by Takeda Pharmaceuticals America, Inc.
-
FDA approval · 2011-04-27FDA Approved: FOSRENOL — Supplemental Application (Takeda Pharmaceuticals America, Inc.)
The FDA approved a supplemental application for FOSRENOL (lanthanum carbonate) submitted by Takeda Pharmaceuticals America, Inc.
-
FDA approval · 2011-03-09FDA Approved: EXTRANEAL — Supplemental Application (Vantive US Healthcare LLC)
The FDA approved a supplemental application for Extraneal (icodextrin) solution submitted by Vantive US Healthcare LLC.
-
FDA approval · 2009-09-14FDA Approved: DELFLEX — Supplemental Application (Fresenius Medical Care de Mexico, S.A. de C.V.)
FDA issued a supplemental approval for DELFLEX, a multicomponent dialysis solution, manufactured by Fresenius Medical Care de Mexico, S.A. d…
-
FDA approval · 2009-09-14FDA Approved: DELFLEX — Supplemental Application (Fresenius Medical Care North America)
The FDA approved a supplemental application for DELFLEX, a dialysate solution, from Fresenius Medical Care North America.
-
FDA approval · 2009-08-20FDA Approved: ZEMPLAR — Supplemental Application (AbbVie Inc.)
FDA approves a supplemental application for ZEMPLAR (paricalcitol) submitted by AbbVie.
-
FDA approval · 2009-08-12FDA Approved: SEVELAMER CARBONATE — Original Application (Sanofi-Aventis U.S. LLC)
FDA approved Sevelamer carbonate (brand Renvela) via an original NDA to treat hyperphosphatemia in adults with chronic kidney disease on dia…
-
FDA approval · 2009-04-07FDA Approved: EXTRANEAL — Supplemental Application (Vantive US Healthcare LLC)
The FDA approved a supplemental application for Extraneal (icodextrin-based peritoneal dialysis solution) submitted by Vantive US Healthcare…
-
FDA approval · 2009-01-29FDA Approved: EXTRANEAL — Supplemental Application (Vantive US Healthcare LLC)
The FDA approved a supplemental application for Extraneal. The product is an icodextrin-based peritoneal dialysis solution containing icodex…
-
FDA approval · 2008-12-19FDA Approved: DIANEAL LOW CALCIUM WITH DEXTROSE — Supplemental Application (Vantive US Healthcare LLC)
FDA approved a supplemental application for Dianeal Low Calcium with Dextrose, a peritoneal dialysis dialysate solution manufactured by Vant…
-
FDA approval · 2008-10-02FDA Approved: FOSRENOL — Supplemental Application (Takeda Pharmaceuticals America, Inc.)
The FDA approved a supplemental application for Fosrenol (lanthanum carbonate) submitted by Takeda Pharmaceuticals America, Inc.
-
FDA approval · 2008-05-06FDA Approved: DELFLEX — Supplemental Application (Fresenius Medical Care North America)
The FDA approved a supplemental application for DELFLEX, a dialysate solution containing dextrose and electrolytes, submitted by Fresenius M…
-
FDA approval · 2008-04-10FDA Approved: FOSRENOL — Supplemental Application (Takeda Pharmaceuticals America, Inc.)
FDA approved a supplemental application for FOSRENOL (lanthanum carbonate) from Takeda Pharmaceuticals America, resulting in an approved lab…
-
FDA approval · 2008-02-26FDA Approved: CALCIUM ACETATE — Original Application (Hikma Pharmaceuticals USA Inc.)
FDA approved Hikma Pharmaceuticals USA Inc.'s calcium acetate for use as a phosphate binder in patients with hyperphosphatemia due to chroni…
-
FDA approval · 2007-08-23FDA Approved: DIANEAL LOW CALCIUM WITH DEXTROSE — Supplemental Application (Vantive US Healthcare LLC)
FDA approved a supplemental application for Dianeal Low Calcium with Dextrose, a peritoneal dialysis solution from Vantive US Healthcare LLC…